RGCRegencell Bioscience HoldingsRGC info
$6.61info1.54%24h
Global rank22068
Market cap$86.02M
Change 7d-23.50%
YTD Performance-37.05%
SP500 benchmarkUnderperform
P/E-14.69
P/S0
Revenue$0
Earnings-$6.06M
Dividend yield-
Main Sector
Healthcare

EPS for Regencell Bioscience Holdings (RGC)

Regencell Bioscience Holdings has an EPS of $-0.45. In 2022, the company made an earnings per share (EPS) of $-0.58. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.

EPS for RGC

-
Value:-

EPS history for Regencell Bioscience Holdings from 2001 to 2023

YearEPSChange
2023-$0.45-22.41%
2022-$0.58444.45%
2021-$0.10652965.78%
2020-$0.064259-

View the highest EPS stocks

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org